Boomtown

[ProfitScout]

$RENB Renovaro, Amsterdam UMC Cancer Center Plan to Form Joint Venture for Cancer Immunotherapy
Click here:
https://www.marketscreener.com/quote/stock/RENOVARO-INC-47536345/news/Renovaro-Amsterdam-UMC-Cancer-Center-Plan-to-Form-Joint-Venture-for-Cancer-Immunotherapy-46820158/ @Nasdaq @Marketscreener1 #collaboration

[Alexulf]

ESM Responds to EU Commission Call For Strategic Mining Projects!

https://ceo.ca/@globenewswire/euro-sun-mining-responds-to-european-commission-call

Part of article;

ESM wishes to confirm that the Company has formally begun proceedings to list its Rovina Valley Project (the “Project”)
with the European Commission as a “strategic project” for the European supply of critical minerals.

Following a meeting held on May 27, 2024 with the Romanian Ministry of Economy, the application for the Project to be
designated as a “strategic project” within the European Commission’s Critical Raw Materials Act was sanctioned.

This positive development will take place whilst Romania continues towards overhauling its
existing mining legislation to align with the Critical Raw Materials Act.

IMO very important news, yet the market do not react (so far?), with a gain in the share price - maybe a delayed effect will play out.

With the project officially supported by the EU commision, the Romanian side will also play ball - no more stalling -
cause now it`s in the interest of the new government to succeed with it, not only the company itself -
the CEO`s 4% stake of OS is also a significant fact that will pay of to shareholders.

BULLISH

[BlazingStocks]

$BDCC - A product of prestigious universities, Mohammed's academic background in Civil Engineering serves as the bedrock of his illustrious career, providing him with the technical proficiency and strategic insight necessary to navigate the complexities of the industry with unparalleled finesse.
https://finance.yahoo.com/news/blackwell-3d-corporation-secures-services-040533630.html

[BlazingStocks]

$AGBA News May 21, 2024

AGBA/Triller $4bn Merger: Excellent Progress Ahead of Plan
https://www.marketwatch.com/press-release/agba-triller-4bn-merger-excellent-progress-ahead-of-plan-fbd7e5fe?mod=mw_quote_news_seemore

[ProfitScout]

$SHOT: Safety Shot Partners with Capital Drugs To Launch World's First Beverage To Reduce Blood Alcohol Content in 300 Pharmacies Across the Country

The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide

JUPITER, Fla., June 6, 2024 /PRNewswire/ -- Safety Shot, Inc. (Nasdaq: SHOT) (the "Company), announced today its partnership with Capital Drugs as the brand expands its nationwide availability. Making strides in connecting the brand to its overarching wellness purpose, Safety Shot will be available in all 300 of the drugstore chain's pharmacies across the United States.

Entering a key market for Safety Shot consumers, Capital Drugs is known for providing a wide range of pharmaceutical services and products tailored to specific health and wellness needs. Capital Drugs offers traditional pharmacy and clinical services in tandem with alternative medicine options such as supplements, vitamins, and homeopathic products.

"Entering Capital Drugs pharmacies is an integral next step in furthering Safety Shots key messaging and purpose of operating as a functional wellness beverage," said Josh Wagner, Chief Revenue Officer at Safety Shot. "Expanding on-shelf availability and having the product available for purchase in key locations like Capital Drug pharmacies is the brand's core mission, introducing the first-of-its-kind beverage to a like-minded consumer audience."

This latest affiliation aligns with the brand's comprehensive nationwide availability rollout and partnership expansion plan. This announcement comes on the heels of its Northeast expansion across New York and New Jersey through boutique broker Prime CBS and additional partnerships with GoPuff, BevMo and more.

About Safety Shot, Inc

Safety Shot, Inc., a wellness and dietary supplement company, has developed Safety Shot, the first patented wellness product on Earth that lowers blood alcohol content by supporting its metabolism, while boosting clarity, energy and overall mood. Safety Shot is available for purchase online at DrinkSafetyShot.com and Amazon. The Company is introducing business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars throughout 2024.

SOURCE Safety Shot

[Value_Investor]

ASTI did Rapidly surge to $0.203 from $0.1131 on June 3! However, it crashed down to $0.095 today! So, it may Quickly bounce up to test $0.2xxx again as soon as the coming week...

ASTI is currently at Extremely Oversold status --- from its most Recent high $0.34 (on May 23) to current Ridiculous-Low price levels $0.09xx!

[Value_Investor]

TTNXP was Up over 21% in After-Hour session on June 13 after Good News (see the link below)! Last January it did Quickly surge 5.2-Bagger to Pre-R/S's $1.456 from Pre-R/S's $0.28 --- see the first chart below!

https://www.otcmarkets.com/filing/html?id=17619193&guid=cqQ-kamb8r4T4rh

This Hidden Gem is also at Hyper Oversold status --- from May 17's high $6.72 to June 13's Super-Ridiculous-Low price $1.08!

This Diamond_In_Rough has Shocking Huge Positive Book Value (BV) --- $36.22 a share which is 33.54 Times of Super-Ridiculous-Low price $1.08! Also it has Huge Positive Cash Value --- $2.36 a share which is 2.19 Times of Super-Ridiculous-Low price $1.08!

That means that TNXP is Super Undervalued now! Easy to surge over May 17's high $6.72!

TNXP is the Cheapest Bio-Tech NASDAQ stock with the Highest BV/PPS Ratio up to 33.54!

There is a 3.2-Bagger Huge Price-Gap between $3.84 and June 12's high $1.2! So, we'll soon see a 5.2-Bagger+ Easy & Quick Rally again!

Note, the 50-Day MAL is at $5.13 from the second chart below!

Hopefully as soon as next week the company will issue some Very Good News to trigger the Upcoming 5.2-Bagger+ Huge Rally...

[BlazingStocks]

$AGBA News June 12, 2024

AGBA/Triller $4bn Merger: The Group files its Preliminary Proxy Statement
https://finance.yahoo.com/news/agba-triller-4bn-merger-group-122000311.html

[BlazingStocks]

$FAVO News June 11, 2024

FAVO Capital, Inc. Appoints Turner, Stone & Company, LLP as Auditors
https://finance.yahoo.com/news/favo-capital-inc-appoints-turner-171500774.html

[Alexulf]

PlantX Life - Certain things taking place lately, makes me for now to be more carefull, I do simply need to check in to new developments/troubles?

So, it`s a HOLD from my side - do your own research on all parts of PlantX.

[BlazingStocks]

$AGBA - Triller now fully focuses on pooling its resources and attention towards completing the proposed merger with AGBA within a short timetable.
https://www.marketwatch.com/press-release/agba-triller-4bn-merger-excellent-progress-ahead-of-plan-fbd7e5fe?mod=mw_quote_news_seemore

[BlazingStocks]

$FAVO - This accolade celebrates Stewards Investment Capital's instrumental role in facilitating the ground-breaking acquisition of FAVO Capital, resulting in FAVO Capital's acquisition of all entities forming the FAVO Group of Companies.
https://finance.yahoo.com/news/favo-capital-stewards-investment-capital-171000225.html

[ProfitScout]

$GV News: Broader Development Opportunities for PSW Sector

TORONTO, June 7, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the cooperation with Canadian International Career College (CICC) will have broader development opportunities.

On June 3, 2024 the Honourable Marc Miller, Minister of Immigration, Refugees and Citizenship announced two pilot programs that allow caregivers to directly obtain PR status upon arrival in Canada.

The new pilot programs require caregivers to have a full-time job offer for a home care position, relevant work experience, a language proficiency of CLB (Canadian Language Benchmarks) level 4, and an education level equivalent to a Canadian high school diploma. These new pilot programs expedite the immigration process for caregivers coming to Canada to care for children, the elderly, and people with disabilities. Caregivers can also work for organizations that provide temporary or part-time care services to individuals who are semi-independent or recovering from injuries. This new pathway means that caregivers can more easily find employers.

This news is extremely beneficial for the PSW (Personal Support Worker) industry. the Company's subordinate Farvision Career Education Group Inc signed a cooperation agreement with Canadian International Career College to explore the market in Asia on May 9,2024. We believe with the implementation of the two pilot programs in Canada, we will have more support for our development in the Asian market. The company will expedite its efforts to develop the Asian market.

The Canadian International Career College (CICC) provides Personal Support Worker Certificate, Medication Administration for PSW Certificate Course, Early Childcare Assistant (ECA) Diploma Course, Intensive Care Unit (ICU) Program for Nurse Certificate Course, Medical Surgical Certificate Course, CPR/AED Certificate Course, Standard First Aid with CPR Course, and Business Programs.

About Visionary Holdings Inc.

Visionary Holdings Inc. headquartered in Toronto, Canada, is a private education provider located in Canada, with subsidiaries in Canada and market partners in China, that offers high-quality education resources to students around the globe. The Company aims to provide access to secondary, college, undergraduate and graduate and vocational education to students in Canada through technological innovation so that more people can learn, grow and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the Company has been serving and will continue to serve both Canadian and international students. For more information, visit the Company's website at https://ir.visiongroupca.com/.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "believes," "expects," "anticipates," "estimates," "intends," "would," "continue," "should," "may," or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.

For more information, please contact:

Visionary Holdings Inc.
Investor Relations Department
Email: [e-mail]



https://c212.net/c/img/favicon.png?sn=CN34236&sd=2024-06-07 View original content:https://www.prnewswire.com/news-releases/broader-development-opportunities-for-psw-sector-302167022.html

SOURCE Visionary Holdings Inc.

[Value_Investor]

BRLL has 450M shares Large AS and 382,837,825 shares Huge OS but it ever hit $3 recently with Very Ridiculous High MV ($13,399,324 ~ $1,339,932) based on its 52-week price range of $0.0035 ~ $0.035 v.s. its Much-Much-Much-Smaller-SS peer AFFL only has 250M shares Tiny AS and 24,554,116 shares Super Tiny OS but it is trading at Super Ridiculous Low price levels $0.0295 ~ $0.02 most recently with Super Ridiculous Low MV ($724,346 ~ $49,108) based on its 52-week price range of $0.0020 ~ $0.0295!

Buying BRLL at its recent high $3.00 = buying AFFL at $46.7748 which is 1586 Times of its current super ridiculous low 52-week-high $0.0295!

Buying BRLL at its 52-week-high $0.035 = buying AFFL at $0.5457 which is 18.5 Times of its current super ridiculous low 52-week-high $0.0295!

Buying BRLL at its 52-week-low $0.0035 = buying AFFL at $0.0546 which is 27.3 Times of its current super ridiculous low 52-week-low $0.0020!

BRLL has -$6,090,794 Huge Negative Net Asset v.s. AFFL only has -$26,445 minor negative Net Asset!

[ProfitScout]

$GV News: Top Reasons to Have GV on Your Radar

TORONTO, June 4, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the top reasons to have GV stocks.

Strategic Transition: In response to changing education policies, GV strategically transitioned from traditional education to high technology, life sciences, and AI education, positioning itself at the forefront of innovation.

Diversification of Revenue Streams: With a focus on high-tech and AI education, GV expanded its revenue streams beyond traditional education, tapping into lucrative markets in technology, life sciences, and artificial intelligence.

Expansion into New Markets: Through collaborations with global partners, GV expanded its market presence beyond Canada, leveraging its expertise in education technology to tap into international markets.

Innovative Education Programs: GV introduced innovative education programs, including the Algoma University Learners Early Access Program (LEAP), offering students unique pathways to postsecondary education and fostering international collaboration.

Strong Leadership: Under the guidance of experienced leadership, including CEO Mr. Zhong Chen, GV has executed strategic initiatives effectively, driving growth and innovation in the high technology, life sciences, and AI education.

Global Collaborations: Our strategic alliances with industry leaders such as Red Sun Group and Shenzhen Guoli Intelligent Technology Group amplify our reach and capabilities. These partnerships facilitate groundbreaking initiatives in life sciences, AI education, and STEM, driving innovation and value creation.

Cutting-Edge Biochip Technology: With our partnership with Canada BRAUN Bio Technology Group Inc., Visionary is at the forefront of biochip technology. Our world-class products address critical needs in medical testing, drug development, and more, positioning us as leaders in Canada's burgeoning biotech sector.

New Energy Vehicles: Visionary Group, is having intention to collaborate with Farnova Holding Group, which will be Canada's first independent brand of new energy vehicles. This initiative addresses a critical need in the market and promotes eco-conscious transportation solutions.

About Visionary Holdings Inc.

Visionary Holdings Inc. headquartered in Toronto, Canada, a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China. The Company aims to provide access to secondary, college, undergraduate and graduate and vocational education to students in Canada through technological innovation so that more people can learn, grow and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the Company has been serving and will continue to serve both Canadian and international students. For more information, visit the Company's website at https://ir.visiongroupca.com/.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "believes," "expects," "anticipates," "estimates," "intends," "would," "continue," "should," "may," or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.

For more information, please contact:

Visionary Holdings Inc.
Investor Relations Department
Email: [e-mail]

https://c212.net/c/img/favicon.png?sn=CN30587&sd=2024-06-04 View original content:https://www.prnewswire.com/news-releases/top-reasons-to-have-gv-on-your-radar-302162725.html

SOURCE Visionary Holdings Inc.

[ProfitScout]

$AVRW News: Avenir Wellness Solutions Reports Fourth Quarter 2023 Results

New Initiatives Showing Encouraging Results

SHERMAN OAKS, CA / ACCESSWIRE / May 17, 2024 / Avenir Wellness Solutions, Inc. (OTCQB:AVRW) ("Avenir" or the "Company" , a proprietary broad platform technology and wellness company, today announced results for the fourth fiscal quarter ended December 30, 2023.

Key financial highlights for the fourth quarter included the following:

Net revenue in the fourth quarter of 2023 increased to $1.1 million from the same period in 2022 by $0.2 million, or 11.7%, and also increased sequentially from Q3 2023 by $43 thousand, or 4.4%. Overall growth was lower than expected due to the continued delay in receiving the expected remainder of the asset sale proceeds to be used for advertising and marketing to drive sales. The quarter did, however, benefit from a new relationship with leading online and beauty subscription box retailer, FabFitFun.

Gross margin increased 407 basis points year over year in the fourth quarter of 2023 due to improved working capital management offset in part by a higher proportion of sales coming from our wholesale channel of distribution with its lower margins than our higher-margin direct-to-consumer sales channel.

Gross margin for the third quarter of 2023 decreased sequentially from the second quarter of 2023 by 26 basis points due to a shift in sales channel mix with a higher proportion of wholesale sales to Amazon and FabFitFun which resulted in shipments of approximately $0.3 million.

Cost containment initiatives led to a favorable impact on SG&A expenses (excluding non-cash charges) for the fourth quarter with a decrease of $357 thousand in 2023 compared to 2022 driven by decreased spend on advertising and promotion of $325 thousand lower overhead by $32 thousand.

Net operating loss from continuing operations (excluding non-cash charges) improved by $0.9 million in 2023.

"Our products continue to maintain sales levels which is encouraging given that we have been unable to fully execute on our marketing initiatives pending receipt of the balance of the proceeds from the July 2022 asset sale. As mentioned in our third quarter earnings announcement, the proceeds from the July 2022 asset sale allow us to invest in the future of the Company, but the delay in receiving the balance of the proceeds continued to have an impact on our operating performance. We expect accelerating sales will reaffirm the improving overall trajectory of the business. Further, our margin expansion initiatives continue to deliver results with improvement from third quarter, and we continue our overall cost containment initiatives to further reduce SG&A expenses and to maximize operating leverage.

Fine tuning our Search Engine Optimization (SEO), bringing our media buying in house and achieving successful monthly campaigns like theSkimm continue to deliver for us as we execute on our strategy to build our brands," said Nancy Duitch, Avenir CEO.

Operational Highlights

Other operational highlights during the fourth quarter of 2023 included:

Our newly formulated Seratopical Revolution Cracked Heel Souffle was selected for inclusion in FatFitFun's Summer 2024 subscription box selling out an astonishing 80,000 units in under 43 minutes. Click link to view Instagram videos on our Cracked Heel Souffle.
Our DNA Complex hero product continues to perform as our subscription based grows.
Wholesale sales led by Amazon continue to grow with all the positive product reviews.
We began development of our new TikTok shop to capitalize on the evolving digital ecommerce landscape which launched in the second quarter of 2024.
For further details, please visit our website to review our most recent Form 10-K filed on May 17, 2024 at: http://www.avenirwellness.com/sec-filings/

About Avenir Wellness Solutions, Inc.

Avenir Wellness Solutions, Inc. (OTCQB:AVRW) is a broad platform technology company that develops proprietary wellness, nutraceutical, and topical delivery systems which are integrated into our wellness and beauty products and sold directly to the consumer. The technology, which is based on (15) fifteen current patents, offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new technologies that is part of its incubator strategy in order to monetize its intellectual property as well as expand our product lines utilizing the technology. As a vertically integrated platform company, Avenir looks to partner or license its IP technology with wellness companies worldwide. For more information visit: http://www.avenirwellness.com.

About The Sera Labs, Inc.

Sera Labs, a wholly owned subsidiary of Avenir, is a trusted leader in the health, wellness, and beauty sectors of innovative products with cutting-edge technology. Sera Labs creates high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale. Strategically positioned in the growth market categories of beauty, health and wellness, Sera Labs products are sold direct-to-consumer (DTC) via online website orders, including a subscribe and save option, and also sold online and in-store at major national drug, grocery chains, convenience stores, and mass retailers and on Amazon.com. For more information visit: www.seralabshealth.com and follow Sera Labs on Facebook, Instagram and TikTok at @seratopical as well as on X (Twitter) at @sera_labs.

Forward Looking Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.

Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.

CONTACTS:

Investor Relations
Hanover International Inc.
T: [phone]
E: [e-mail]

SOURCE: Avenir Wellness Solutions, Inc. (f/k/a Cure Pharmaceutical Holding Corp.)

[Value_Investor]

SSHT has 1B shares Huge AS and 109,903,473 shares Large OS but it ever hit $4.1 recently with super ridiculous high 52-week price range of $0.2951 ~ $1.16 v.s. its Much-Much-Much-Smaller-SS peer AFFL only has 250M shares Tiny AS and 24,554,116 shares Super Tiny OS but it is trading at super ridiculous low price levels $0.0295 ~ $0.02 most recently with super ridiculous low 52-week price range of $0.0020 ~ $0.0295!

Buying SSHT at $4.1 = buying AFFL at $18.51 which is 712 Times of its current ridiculous low price $0.026!

Buying SSHT at $0.2951 = buying AFFL at $1.3209 which is 51 Times of its current ridiculous low price $0.026!

SSHT has -$54,256 Net Asset v.s. AFFL has -$26,445 Net Asset!

[BlazingStocks]

$FAVO - recognized by Global Finance for the Best Fixed Income Investment Innovation Award as part of their Annual Top Innovation in Finance Awards for 2024.
https://finance.yahoo.com/news/favo-capital-stewards-investment-capital-130500781.html

[ProfitScout]

$GV News: GV Announces Cooperation with CICC

TORONTO, May 22, 2024 /PRNewswire/ -- Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced the Company's subordinate Farvision Career Education Group Inc signed a cooperation agreement with Canadian International Career College to explore the market in Asia on May 9,2024.

As Canada's aging population continues to rise, the government has implemented various measures to address the issue by attracting foreign workers to the PSWs sector. According to the Canadian Association of Senior Housing and Care Providers, the healthcare sector contributes over CA$100 billion to the Canadian economy each year.

The shortage of labor has resulted in a critical need for foreign workers in the personal support worker (PSW) field to fill the workforce gap and provide essential care and support to seniors and individuals with disabilities.

In addition to the economic benefits, the influx of foreign labor as PSWs also has a positive impact on the Canadian healthcare system. PSWs often serve as the primary caregivers for seniors and individuals with disabilities, playing a crucial role in assisting them with daily activities and maintaining their independence.

The courses offered by the Canadian International Career College (CICC) include Personal Support Worker Certificate, Medication Administration for PSW Certificate Course, Early Childcare Assistant (ECA) Diploma Course, Intensive Care Unit (ICU) Program for Nurse Certificate Course, Medical Surgical Certificate Course, CPR/AED Certificate Course, Standard First Aid with CPR Course, and Business Programs.

After completing all courses and passing exams, Farvision Career Education Group and CICC will assist students in obtaining work visas and provide job referrals. For local Chinese students, they can complete remote courses in China and receive certificates recognized by both China and the province of Ontario, Canada, upon passing exams.

This project will bring a new revenue growth point to the Company.

About Visionary Holdings Inc.

Visionary Holdings Inc. headquartered in Toronto, Canada, a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China. The Company aims to provide access to secondary, college, undergraduate and graduate and vocational education to students in Canada through technological innovation so that more people can learn, grow and succeed to their full potential. As a fully integrated provider of educational programs and services in Canada, the Company has been serving and will continue to serve both Canadian and international students. For more information, visit the Company's website at https://ir.visiongroupca.com/.

Forward-Looking Statements

All statements other than statements of historical fact in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company's current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as "believes," "expects," "anticipates," "estimates," "intends," "would," "continue," "should," "may," or similar expressions. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and in its other filings with the SEC.

For more information, please contact:

Visionary Holdings Inc.
Investor Relations Department
[e-mail]

Cision View original content:https://www.prnewswire.com/news-releases/gv-announces-cooperation-with-cicc-302152260.html

SOURCE Visionary Holdings Inc.

[Value_Investor]

KXIN (NASDAQ-Exchange stock) is at Hyper Oversold status now --- from May 17's pre-market high $0.6 to last Friday's daily low $0.15 which is 75% price crashing within just a week!

Easy to surge back to $0.6 again within just a couple of days just like it did a week ago...

Note, the 52-week-high is $6.6 which is 11 Times of $0.6!

[Zardiw]

$CATV Trading at 1/2 of Book Value.....

Z

[Alexulf]

ES Mining successfull meeting with Ministry of Economy (December 2023) and the Romanian Ministry of Environment, Water, and Forests (January 2024).

https://www.theglobeandmail.com/investing/mar.../research/

https://www.eurosunmining.com/wp-content/uplo...un-PPT.pdf

[BlazingStocks]

$AGBA Squeeze coming. Triller $4bn Merger Update this week, Excellent Progress Ahead of Plan.

Expecting more updates really soon.

https://www.reddit.com/r/Shortsqueeze/s/gv7mTzj0Og

[Value_Investor]

AFFL has $18.51 Analyst's Target based on its OTC peer's MV at its most recent high $4.1! Once the Upcoming Reverse-Merger deal kicks in, this hidden gem (24,354,116 shares Tiny OS and 250M shares Tiny AS) will soar to $18.51 in order to match the Same MV with SSHT (109,903,473 shares Large OS and 1B/1000M shares Huge AS) at its peak!

Note, the Analyst's Target $18.51 is equal to 208 Times of its recent high $0.089!

This CLEAN Shell has a Sought-After FIXED Tiny Shares Structure and a Super-Positive Neat Financial Balance Sheet! It is easy to be Up-Listed to the NASDAQ Exchange after the Upcoming Reverse-Merger deal……

AFFL is Super Undervalued now --- mere $367,747.15 MV at current ridiculous low price $0.0151 v.s. its peer did hit $450,604,239.30 MV most recently!

AFFL is at Hyper Oversold status --- from its recent high $0.089 to current Super ridiculous low 52-week-low $0.0020!

[Alexulf]

UP X 2 Or DOUBLE right now, see the PlantX board, as this is only the beginning.

https://investorshub.advfn.com/PlantX-Life-Inc-VEGA-38643

[ProfitScout]

$GRLF: Green Leaf Innovations, Inc. Sets Sail for History

Join Cubanacan Heritage at Battleship New Jersey Museum's Annual 'Cigars on the River' Event

PEMBROKE PINES, FL / ACCESSWIRE / May 15, 2024 / Green Leaf Innovations, Inc., (OTC PINK:GRLF), an importer and wholesale distributor of premium hand-rolled cigars, is proud to announce its participation in the highly anticipated 'Cigars on the River' event at the iconic Battleship New Jersey Museum and Memorial.

Overlooking the majestic Delaware River and the breathtaking Philadelphia skyline, this annual soirée promises an unforgettable evening of indulgence and philanthropy. Guests will savor the finest cigars, exquisite cuisine, and handcrafted cocktails amidst the historic setting of the Battleship New Jersey.

Cubanacan Heritage, a cornerstone of Green Leaf Innovations, Inc.'s esteemed portfolio, will take center stage at this prestigious event, showcasing the rich heritage and unrivaled craftsmanship behind each meticulously hand-rolled cigar.

About Battleship New Jersey Museum and Memorial: The Battleship New Jersey Museum and Memorial stands as a testament to our nation's military prowess and enduring legacy. From its storied past in World War II to its pivotal role in modern naval history, the battleship offers a captivating glimpse into the triumphs and sacrifices of our armed forces. Immerse yourself in a journey through time and honor the heroes who have served our country with courage and valor.

Don't miss this exclusive opportunity to join Green Leaf Innovations, Inc. and Cubanacan Heritage aboard the Battleship New Jersey for an evening of camaraderie, celebration, and support for a noble cause.

About Green Leaf Innovations, Inc.

Green Leaf Innovations, Inc., a Florida corporation, is an emerging growth company engaged in the Marketing and Distribution of handmade premium cigars. The company strategically imports and exclusively distributes some of the best known premium cigar brands in the Market created by the Mederos family a Third generation Cigar maker with Robert Mederos at the helm who has owned and operated handmade cigar operation in Nicaragua and the US for over 20 years with a rich family history in the craft dating back to the 1800s Cuba, brands such as CUBANACAN, MEDEROS and TABACALERA SERRANO. In addition to it the company also distributes packaged whole leaf Tobacco to cigar lounges, smoke shops, C-stores and vape shops across the United States and soon International Markets.

Additional information can be found on our websites http://www.greenleafinnovation.com or follow us on Twitter @otcgrlf.

For more information, press only:

PR Contact Name: Ryan Medico
Phone number: [phone]
Email: [e-mail]

Safe Harbor Statement:

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. The Company may also make written or oral forward-looking statements in its filings with the U.S. Securities and Exchange Commission, in press releases and other written materials, and in oral statements made by its officers, directors or employees to third parties. There can be no assurance that such statements will prove to be accurate. The Company cautions that these forward-looking statements are further qualified by other factors including, but not limited to, those set forth in the Company's Annual Reports on Form 10-K and its other filings with the Securities and Exchange Commission. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control. The Company does not undertake any obligation to update publicly or to revise any statements in this release, whether as a result of new information, future events, or otherwise.

SOURCE: Green Leaf Innovations, Inc.

[Bansky]

$EBYH Strainsforpains reporting 136k revenues first quarter! last 4 months it has booked 200k. They will be dramatically increasing in sales when they go national. CBD relief for pain.

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.otcmarkets.com/otcapi/company/financial-report/403167/content

[BlazingStocks]

$AGBA Article May 08, 2024

Triller CEO says deal with Bob Diamond-backed AGBA will revitalize social media push
https://www.axios.com/pro/media-deals/2024/05/08/triller-ceo-says-deal-with-bob-diamond-backed-agba-will-revitalize-social-media-push

[Alexulf]

Chicago’s New Taco Restaurants!!!

https://vegainvestors.com/news/chicagos-essen...staurants/

https://investorshub.advfn.com/PlantX-Life-Inc-VEGA-38643

[ProfitScout]

$CCTG News: CCSC Technology International Holdings Limited Announces Plan for New Supply Chain Management Center in Central Europe

Thu, May 16, 2024, 8:00 AM EDT

In this article: $CCTG -CCSC Technology International Holdings Limited

Hong Kong, May 16, 2024 (GLOBE NEWSWIRE) -- CCSC Technology International Holdings Limited (the “Company” or “CCSC”) (Nasdaq: CCTG), a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products, including connectors, cables and wire harnesses, today announced that the Company plans to commence construction of a new Europe supply chain management center (the “Center”) located in Municipality of Merosina, Republic of Serbia (“Serbia”), in August 2024. The 50,000-square-meter facility will be CCSC’s first supply chain center project and is scheduled for completion in 2025. Once completed, it will serve as the headquarters of the Company's supply chain operations in Europe.

To further optimize production efficiency and boost synergy, in February 2024, CCSC formed a new subsidiary, CCSC Technology Doo Beograd, in Belgrade, Serbia. This subsidiary will be responsible for the operations of our new Europe supply chain management. The Company plans to adopt modern automation solutions and three-dimensional storage technology to optimize the use of the storage space, and leverage the latest digital technologies to build a smart supply chain management platform at the Center. The facility will serve as a key integrated supply chain transit hub, supporting the Company's operations across Europe.

This project is fully supported by the Merosina government, with a signed memorandum of understanding marking the collaboration between CCSC Technology Doo Beograd and the Municipality of Merosina. The total investment for the Center is estimated at US$6 million.

Mr. Kung Lok Chiu, Chief Executive Officer and Director of the Company, commented, "As part of our on-going strategic plan, we will continue to widen our strategic moat by investing in supply chain infrastructure to further enhance the agility and resiliency of our business. We believe our new Center will better support our business by driving long-term growth. This initiative is also crucial in our endeavors to become a leader in the interconnect products market. We are committed to adopting the most advanced technologies, developing replicable and scalable solutions, and fostering innovative ideas and products."

About CCSC Technology International Holdings Limited

CCSC Technology International Holdings Limited, is a Hong Kong-based company that engages in the sale, design and manufacturing of interconnect products. The Company specializes in customized interconnect products, including connectors, cables and wire harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. The Company produces both OEM (“original equipment manufacturer”) and ODM (“original design manufacture”) interconnect products for manufacturing companies that produce end products, as well as electronic manufacturing services (“EMS”) companies that procure and assemble products on behalf of such manufacturing companies. The Company has a diversified global customer base located in more than 25 countries throughout Asia, Europe and the Americas. For more information, please visit the Company’s website: http://ir.ccsc-interconnect.com.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements, including, but not limited to, the Company's proposed Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “may,” “will,” “could,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “is/are likely to,” “propose,” “potential,” “continue”, or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the U.S. Securities and Exchange Commission.

For more information, please contact:

CCSC Technology International Holdings Limited
Investor Relations Department
Email: [e-mail]

Ascent Investor Relations LLC
Tina Xiao
Phone: [phone]
Email: [e-mail]

[Zardiw]

$KBLB Chart from #DDAmanda - #1 Stock Screener :

Find Winners Early.



Z

[Alexulf]

PLANTX Life 1 year forecast $3.5310, a +17082.70%
increase from the current price of $0.0206.
https://stockscan.io/stocks/PLTXF/forecast

https://investorshub.advfn.com/PlantX-Life-Inc-VEGA-38643

Bullish

[BlazingStocks]

Amazing News from $RENB...

$RENB - unveils Flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing (ULP-WGS) of cell-free DNA (cfDNA), Flamingo represents a promising leap forward in the fight against cancer.
https://finance.yahoo.com/news/transforming-cancer-detection-renovarocube-introduces-150000564.html
$TWST

[Alexulf]

Delicious DOUGHNUTS Done Right in Chicago!

https://vegainvestors.com/news/delicious-doug...n-chicago/

24th of Aptil this news came out - see link above.

Is there anything better than a doughnut? In all of its manifestations — a ring, a circle, a rectangle, a stick, filled with cream, stuffed with fruit, dunked in chocolate, buried under a mound of powdered sugar — a doughnut is a perfect pick-me-up, the epitome of a cheap luxury.


Here are 23 spots that offer the best doughnuts, and also fritters, beignets, churros, paczki, bismarks, bomboloni, and mochi rings in town.
(see article)

BULLISH - Earnings Report Out On Monday:)

https://investorshub.advfn.com/PlantX-Life-Inc-VEGA-38643 (On OTC as well)

[BlazingStocks]

$PDGO - The recent acquisition underscores Paradigm Oil & Gas, Inc.'s commitment to growth and diversification within the energy sector. By acquiring key assets and stakes in established players, the company seeks to leverage synergies, drive operational efficiencies, and capitalize on emerging opportunities in the oil and gas market.
https://www.otcmarkets.com/stock/pdgo/news/Paradigm-Oil--Gas-Inc-PDGO-Expands-Market-Presence-with-Proposed-Strategic-Oil-and-Gas-Acquisitions?id=439005

[ProfitScout]

$RENB News: Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (Nasdaq: RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cancer detection model contributing to its mission to transform early cancer diagnostics. Leveraging ultra-low pass whole genome sequencing (ULP-WGS) of cell-free DNA (cfDNA), Flamingo represents a promising leap forward in the fight against cancer.

Traditional cancer detection methods often fall short in identifying cancers at an early stage when treatment is the most effective. However, Flamingo has the potential to overcome these limitations by harnessing the power of AI to analyze minute amounts of cfDNA data that is highly accurate.

"At RenovaroCube, we believe in pushing the boundaries of possibility," states Daan Vessies, senior scientist at RenovaroCube. "Flamingo undescores our commitment to change cancer diagnostics in a transformative way, ultimately offering clinicians a powerful tool to detect cancer across diverse omic layers."

The Company believes that no single model or molecular modality will reach the requisite sensitivity and specificity throughout the entire patient journey for personalized, precision medicine, from early detection, to predicting the effectiveness of various treatment options, to monitoring the response to therapy within days of starting it, to detecting recurrence at the earliest possible moment. Therefore, our AI/machine learning platform, The Cube, integrates multi-omic data, offering a uniquely comprehensive approach to cancer detection by leveraging a library of trained models for multiple omic layers. One such model Flamingo focuses on is the detection of cancer from ultra-low pass whole genome sequencing (ULP-WGS) cfDNA data using fragmentomics.

Flamingo's development marks a significant milestone in the quest for early cancer detection with RenovaroCube’s engine. By utilizing as few as only 200,000 cell-free DNA fragments per sample, integrating fragment lengths, sequence motifs and employing a meticulously designed neural network, Flamingo achieves remarkable performance in distinguishing cancer from healthy samples.

By augmenting The Cube's arsenal of models operating across various omic layers, Flamingo contributes to the development of non-invasive diagnostics to detect cancer early, enabling timely interventions and improving patient outcomes.

"Adding Flamingo to our Cube will accelerate our efforts to realize a paradigm shift in cancer detection," affirms Frank van Asch, CTO, RenovaroCube. "With its introduction, we are one step closer to realizing our vision of a world where cancer is detected and treated swiftly, saving countless lives in the process."

RenovaroCube invites interested doctors and scientists from international research institutions, clinical cancer centers and all stakeholders to join in the early research use application of our AI/machine learning platform to advance cancer diagnostics and pave the way for a healthier future.

About Renovaro:

Please see a recent interview with Avram Miller, Member of, and Advisor to, the Board of Directors, former co-founder of Intel Capital and SVP of Business Development for Intel:

https://techbullion.com/avram-miller-talks-ab...es-with-ai

Renovaro aims to accelerate precision and personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better-targeted treatments, and drug discovery. Renovaro includes RenovaroBio, with its advanced cell-gene immunotherapy company, and RenovaroCube. RenovaroCube has developed an award-winning AI platform that is committed to the early detection of cancer and its recurrence and monitoring subsequent treatments. RenovaroCube intervenes at a stage where potential therapy can be most effective. RenovaroCube is a molecular data science company with a background in FinTech and a 10-year history. It brings together proprietary artificial intelligence (AI) technology, multi-omics, multi-modal data, and the expertise of a carefully selected multidisciplinary team to radically accelerate precision medicine and enable breakthrough changes in cancer care.

Upon the closing of the previously announced acquisition of Cyclomics (winner of the Health Holland Venture Challenge), RenovaroCube will be capable of performing liquid biopsies using proprietary technologies to identify single cancer DNA molecules in only one vial of blood. In combination with Oxford Nanopore Technology, genetic information can be retrieved over multiple genetic layers to develop the next generation of cancer diagnostics. This will transform cancer care by enabling faster and more accurate diagnosis throughout the patient journey.

https://www.renovarogroup.com

https://www.renovarobio.com

https://www.renovarocube.com

About Cyclomics:
Cyclomics is a Dutch company founded in 2018, winner of the Health Holland Venture Challenge (startup of the year) by scientists of the UMC Utrecht. Its ambition is to transform cancer care by enabling faster and more reliable diagnoses, particularly in the context of cancer recurrence thanks to its proprietary circulating tumor DNA (ctDNA) detection technology.

https://www.cyclomics.com/

Forward-Looking Statements

Statements in this press release that are not strictly historical in nature are forward-looking statements. These statements are only predictions based on current information and expectations and involve a number of risks and uncertainties, including but not limited to the success or efficacy of our pipeline and platform. All statements other than historical facts are forward-looking statements, which can be identified by the use of forward-looking terminology such as “believes,” “plans,” “expects,” “aims,” “intends,” “potential,” or similar expressions. Actual events or results may differ materially from those projected in any of such statements due to various uncertainties, including as set forth in Renovaro’s most recent Annual Report on Form 10-K filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Renovaro Inc. undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

For media inquiries, please contact: [e-mail]

Source: Renovaro Inc.

[BlazingStocks]

$AGBA Article April 28, 2024

'Baby, We Did It': Conor McGregor Joins BKFC Ownership Team in Shocking Announcement
https://www.si.com/fannation/mma/conor-mcgregor-joins-bkfc-ownership-shocking-move

[BlazingStocks]

$PDGO News April 09, 2024

Paradigm Oil and Gas, Inc. announces its plans going forward.
https://www.otcmarkets.com/stock/PDGO/news/Paradigm-Oil-and-Gas-Inc-announces-its-plans-going-forward?id=436241

[Golden Cross]

$WRIT Copper Soon!

[BlazingStocks]

$WRIT - WRIT Media is thrilled to announce the launch of its innovative NFT Minting Engine, a state-of-the-art blockchain-powered solution designed to revolutionize how digital assets and awards are created, distributed, and valued in live esports competitions and gaming tournaments.
https://www.otcmarkets.com/stock/WRIT/news/New-Era-in-Blockchain-Gaming-Writ-Media-Group-Inc-Announces-Launch-of-Revolutionary-NFT-Minting-Engine-to-Transform-Espo?id=437361

[Golden Cross]

$AGBA Merger - An Overview Of Triller$AGBA - An Overview Of Triller

Triller is a pioneering force in the intersection of technology, entertainment, and commerce, leveraging advanced AI to drive user engagement and content monetization.

▪ Comprehensive digital content and technology platform that caters to creators, brands, and consumers across a global scale.

▪ Recognized for its broad appeal, demonstrated by its significant user base, which includes well-known creators like Charli D’Amelio, Marshmello, Bryce Hall, Jennifer Lopez, Eminem, Da Baby and The Weeknd.

Building the world’s largest space for creators to create, distribute and monetize content



Triller is a pioneering force in the intersection of technology, entertainment, and commerce, leveraging advanced AI to drive user engagement and content monetization.

▪ Comprehensive digital content and technology platform that caters to creators, brands, and consumers across a global scale.

▪ Recognized for its broad appeal, demonstrated by its significant user base, which includes well-known creators like Charli D’Amelio, Marshmello, Bryce Hall, Jennifer Lopez, Eminem, Da Baby and The Weeknd.

Building the world’s largest space for creators to create, distribute and monetize content

[BlazingStocks]

$PDGO News April 09, 2024

Paradigm Oil and Gas, Inc. announces its plans going forward.
https://www.otcmarkets.com/stock/PDGO/news/Paradigm-Oil-and-Gas-Inc-announces-its-plans-going-forward?id=436241

[ProfitScout]

$GDHG -Join us on our journey where every milestone is a testament to our unwavering dedication to creating unforgettable experiences for millions. Together, let's chart a course towards a future filled with growth, profitability, and boundless excitement. https://ir.jsyoule.com

$GDHG -Join us on our journey where every milestone is a testament to our unwavering dedication to creating unforgettable experiences for millions. Together, let's chart a course towards a future filled with growth, profitability, and boundless excitement. https://t.co/o6KKIHgysk pic.twitter.com/1zmNWRmtJN

— Golden Heaven Group Holdings Ltd. (@GoldenHeavenLTD) April 23, 2024

[BlazingStocks]

$CBDL - "We have nearly completed the rebranding and are extremely excited about the upcoming launch, which we expect to announce by mid-May 2024."
https://finance.yahoo.com/news/cbd-life-sciences-provides-exciting-120000086.html

[BlazingStocks]

Impressive News... $NRXP

[ProfitScout]

$NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections

New data demonstrates no impact of NRX-101 on gut or vaginal flora – considered primary causes of pseudomembranous colitis due to C difficile and vaginal yeast infections

NRX-101 previously demonstrated potent activity against resistant urinary pathogens and has been shown to be fully excreted, unmetabolized, in the urine

NRX-101 has received FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designation in Complicated Urinary Tract Infection (cUTI) and Pyelonephritis

RADNOR, Pa., April 17, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals", "NRx", the "Company"), a clinical-stage biopharmaceutical company, today announced new data that demonstrate that in a rodent model NRX-101 shows no measurable damage to either intestinal or vaginal flora, compared to the significant negative effect caused by drugs such as ciprofloxacin. Antibiotics commonly used to treat complicated urinary tract infections (cUTI) are associated with pseudomembranous colitis caused by Clostridium difficile (C diff) and vaginal yeast infections, primarily owing to their impact on normal flora.


C. diff causes an intractable diarrhea in approximately 500,000 Americans each year and kills 1 in 11 Americans over age 65 who contract the infection. Costs of C. diff are estimated at $24,000 per patient and are significantly higher when C. diff occurs as part of a hospital admission. Whereas most antibiotics have substantial effect in the large bowel, the key component of NRX-101 (D-cycloserine) is entirely absorbed in the small intestine and excreted unmetabolized in the urine. If the nonclinical data reported today are replicated in patients, NRX-101 could represent the first antibiotic for cUTI and pyelonephritis that has essentially no risk of causing C. diff infection or vaginal yeast infection. There is an extensive literature surrounding the use of D-cycloserine to treat tuberculosis and cases of C. Diff are unknown.

D-cycloserine's effect as an antibiotic is based on its propensity to substitute for the amino acid alanine in the formation of the bacterial cell wall.

Dr. Michael Manyak, noted Professor of Urology and former Global Medical Director for Urology at Glaxo SmithKline stated "As a Urologist, I'm acutely aware of the importance of avoiding common side effects of current antibiotics. NRX-101's lack of impact on normal flora could potentially confer a distinct advantage for the product in for the treatment of cUTI and pyelonephritis. This profile could change the lives of the half million Americans each year who contract C. diff and save lives among the tens of thousands who die from antibiotic-induced C. diff infections. These potential advantages should make NRX-101 even more attractive to potential partners in this multi-billion-dollar market." Dr. Manyak serves as NRx's Medical Thought Leader for urology.

"While we have primarily focused on NRX-101 as a drug to treat CNS disease, these new and highly provocative findings suggest that NRX-101 could find a home as a first line treatment for cUTI and pyelonephritis, which afflicts more than 3 million Americans each year. Should the rodent model findings prove applicable to the people, the use of NRX-101 to treat cUTI without increasing the risk of C. diff infection could have multibillion dollar potential," said Stephen Willard, JD, Chief Executive Officer of NRx pharmaceuticals.

About D-Cycloserine in cUTI
The active antibiotic ingredient of NRX-101 is D-cycloserine (DCS) that was developed as an antibiotic in the 1950's and used worldwide for the treatment of tuberculosis. However, it fell out of favor with the development of trimethoprim/sulfa and various penicillins, cephalosporins, and tetracyclines, in part because of the CNS effects associated with DCS-induced blockade of the brain's NMDA receptor. In the course of its CNS research, NRx Pharmaceuticals has demonstrated that small doses of lurasidone counteract those CNS effects, potentially providing a new therapeutic life to DCS as an antibiotic. Over the ensuing decades, increased antibiotic resistance has rendered standard treatments for UTI ineffective in many cases and today 3 million Americans suffer from cUTI requiring increasingly toxic antibiotics, increasingly frequent intravenous therapy, and increased need for hospital admission. (Lodise TP, et. al. Open Forum Infectious Diseases https://doi.org/10.1093/ofid/ofac307)

Because DCS has the unique property of being highly concentrated, unmetabolized, in the urine with oral administration, the Company believes, and previous literature has suggested that DCS may effectively treat, and therefore help prevent, the need for intravenous and inpatient treatment of cUTI.

Moreover, because DCS is rapidly absorbed and excreted in the urine, NRX-101 has now been shown to have minimal tendency to disrupt the microbiome of the intestine and vagina and which can lead to secondary Clostridium difficile and/or yeast infections. C. diff associated colitis doubles hospital mortality and costs the American healthcare system up to $1.6 billion each year. (Drozd EM, et. al. Mortality, Hospital Costs, Payments, and Readmissions Associated With Clostridium difficile Infection DOI: 10.1097/IPC.0000000000000299) Additionally, DCS has no known association pulmonary fibrosis, a rare, lethal condition that has been associated with macrolide (tetracycline family) antibiotics.

NRX-101 has received FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations in Complicated Urinary Tract Infection and Pyelonephritis.

About NRx Pharmaceuticals

NRx Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain and PTSD. The Company is developing NRX-101, an FDA-designated investigational Breakthrough Therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRx has partnered with Alvogen and Lotus around the development and marketing of NRX-101 for the treatment of suicidal bipolar depression. NRX-101 additionally has potential to act as a non-opioid treatment for chronic pain, as well as a treatment for complicated UTI.

NRx has recently announced plans to submit a New Drug Application for HTX-100 (IV ketamine), through Hope Therapeutics, in the treatment of suicidal depression, based on results of well-controlled clinical trials conducted under the auspices of the US National Institutes of Health and newly obtained data from French health authorities, licensed under a data sharing agreement. NRx was awarded Fast Track Designation for development of ketamine (NRX-100) by the US FDA as part of a protocol to treat patients with acute suicidality.

About HOPE Therapeutics, Inc.

HOPE Therapeutics, Inc. (www.hopetherapeutics.com) is a Specialty Pharmaceutical Company, wholly-owned by NRX Pharmaceuticals focused on development and marketing of an FDA-approved form of intravenous ketamine for the treatment of acute suicidality and depression together with a digital therapeutic-enabled platform designed to augment and preserve the clinical benefit of NMDA-targeted drug therapy.

Notice Regarding Forward-Looking Statements

The information contained herein includes forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. These statements include, among others, statements regarding the proposed public offering and the timing and the use of the proceeds from the offering. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company's control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company's operations, results of operations, growth strategy and liquidity. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Investors and security holders are urged to read these documents free of charge on the SEC's website at http://www.sec.gov. Except as may be required by applicable law, The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, whether as a result of new information, future events or otherwise.

https://c212.net/c/img/favicon.png?sn=CL90042&sd=2024-04-17 View original content to download multimedia:https://www.prnewswire.com/news-releases/nrx-pharmaceuticals-inc-nasdaqnrxp-announces-new-data-on-nrx-101-demonstrating-no-damage-to-intestinal-and-vaginal-flora-in-validated-rodent-models-compared-to-standard-antibiotics-potential-implications-for-avoidance-of-c--302119157.html

SOURCE NRx Pharmaceuticals, Inc.

[BlazingStocks]

$VGLS Share Structure

Authorized Shares 40,000,000,000 04/05/2024
Outstanding Shares 21,095,499,355 04/05/2024
Restricted 701,073,720 04/05/2024
Unrestricted 20,394,425,635 04/05/2024
https://www.otcmarkets.com/stock/VGLS/security

[BlazingStocks]

$AGBA - AGBA GROUP IS SELECTED AS A STOCK CONSTITUENT TO MSCI GLOBAL MICRO-CAP INDEX
•OVER 30 YEARS IN BUSINESS
•2600 EMPLOYEES
•OVER 400,000 CUSTOMERS

[BlazingStocks]

Read this article - $VVPR still has a bunch of upside.
https://www.nasdaq.com/press-release/does-vivopower-international-nasdaq:vvpr-still-have-more-upside-2024-04-08

[BlazingStocks]

$AGBA News February 15, 2024

AGBA Celebrates Major Milestone with Successful Completion of Private Placement at a Premium to Market Price
https://finance.yahoo.com/news/agba-celebrates-major-milestone-successful-140000317.html